找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Nuclear Receptors; The Art and Science Mostafa Z. Badr Book 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license

[復(fù)制鏈接]
樓主: 獨裁者
31#
發(fā)表于 2025-3-26 21:51:58 | 只看該作者
32#
發(fā)表于 2025-3-27 03:51:49 | 只看該作者
33#
發(fā)表于 2025-3-27 07:05:41 | 只看該作者
34#
發(fā)表于 2025-3-27 13:01:58 | 只看該作者
Design of Novel PPAR Agonist for Neurodegenerative Disease, these partial agonists have been observed to show a favorable impact on insulin sensitivity, blood glucose levels, and dyslipidemia with significantly reduced side effects on human health. Partial agonists have been found to display differences in transcriptional and cellular outcomes by acting thr
35#
發(fā)表于 2025-3-27 14:21:02 | 只看該作者
36#
發(fā)表于 2025-3-27 18:18:42 | 只看該作者
37#
發(fā)表于 2025-3-27 22:03:35 | 只看該作者
38#
發(fā)表于 2025-3-28 05:32:17 | 只看該作者
Androgen Receptors in the Pathology of Disease,cal conditions related to AR dysfunction involve altered levels of androgens and structural alterations in the AR. These include mutations, polymorphisms in the polyglutamine tract of the NTD, and alternative splicing of AR to yield constitutively active receptors. From the extensive list of AR-rela
39#
發(fā)表于 2025-3-28 07:30:36 | 只看該作者
,Bilirubin: A Ligand of the PPARα Nuclear Receptor,other PPAR isoforms PPARβ/δ and PPARγ, and how they function to control peroxisomes and mitochondria that mediates fatty acid β-oxidation and adiposity. There may be clinical interest in bilirubin-PPARα functionality to rectify NAFLD and insulin resistance in the obese.
40#
發(fā)表于 2025-3-28 12:37:42 | 只看該作者
Nuclear Receptor Ligands in Flavivirus Infection Control,est that antagonizing these receptors increases the susceptibility to viral infection. On the other hand, liver X receptors (LXRs) that are involved in cholesterol homeostasis may play a role in flavivirus infection control. LXR agonists have shown to inhibit viral replication via activating cholest
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 23:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
竹溪县| 乐安县| 长岭县| 稷山县| 增城市| 南丰县| 朝阳县| 维西| 布尔津县| 平度市| 全州县| 金坛市| 舒兰市| 张家口市| 桦南县| 临漳县| 韩城市| 德格县| 启东市| 临洮县| 安塞县| 泗阳县| 海阳市| 璧山县| 安国市| 北流市| 永和县| 普兰县| 津南区| 闽清县| 高台县| 乌兰县| 泗阳县| 定襄县| 涿鹿县| 万宁市| 威宁| 中卫市| 天水市| 保康县| 彭州市|